Impact BioMedical, INC. Receivables, Net, Current
Impact BioMedical, INC. (IBO) had Receivables, Net, Current of $199.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:ReceivablesNetCurrent · last filed 2025-11-07
- 2025-09-30: Receivables, Net, Current $199.00K.
- 2025-06-30: Receivables, Net, Current $200.00K.
- 2025-03-31: Receivables, Net, Current $200.00K.
- 2024-12-31: Receivables, Net, Current $201.00K.
| Period end | Receivables, Net, Current |
|---|---|
| 2025-09-30 | $199.00K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $200.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $200.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $201.00K 10-Q · filed 2025-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |